Cost of Incentives to Work Life Balance – Asrar Qureshi’s Blog Post #1258

Asrar Qureshi’s Blog Post 1257 discusses the impact of performance incentives in the pharmaceutical industry. While rewards drive productivity, they can also lead to work-life imbalance, burnout, and a narrow definition of success, emphasizing metrics over well-being. The post advocates for redesigning incentives to promote sustainable practices and prioritize employee wellness.
Share
View Post

Doctors & Pharma Industry – Part 2 of 2 – Asrar Qureshi’s Blog Post #1218

Asrar Qureshi’s Blog Post #1218 addresses the complex relationship between pharmaceutical companies and doctors, emphasizing the need for ethical conduct in Pakistan’s healthcare system. It outlines a Code of Conduct for both sectors, aiming to balance industry collaboration with patient welfare, maintaining professionalism while avoiding conflicts of interest.
Share
View Post

Doctors & Pharma Industry – Part 1 of 2 – Asrar Qureshi’s Blog Post 1217

The blog post by Asrar Qureshi explores the complex relationship between pharmaceutical companies and doctors, emphasizing its dual nature of necessity and ethical risk. It advocates for transparency and independence in education, particularly in the context of Pakistan’s healthcare challenges. The post highlights both issues and contributions of this relationship in improving patient access to treatment.
Share
View Post

Pharma Selling in Five Years – The Shape of Things to Come – Asrar Qureshi’s Blog Post #1147

Asrar Qureshi’s blog post discusses the future of pharmaceutical sales by 2030, highlighting the shift from traditional relationship-driven methods to AI-driven approaches. It predicts a reduction in sales reps, emphasizing targeted engagement and a hybrid selling model. The role of sales reps evolves into that of trusted consultants, leveraging real-time data for better interactions.
Share
View Post

Stressed to Death: When Work Becomes a Silent Killer – Asrar Qureshi’s Blog Post #1096

Asrar Qureshi’s blog post addresses the escalating crisis of workplace stress, particularly within the pharmaceutical industry, linking it to tragic outcomes like premature deaths. It advocates for personal, organizational, and policy-level solutions to combat the stress epidemic, emphasizing the need for a culture that prioritizes employee well-being over relentless productivity.
Share
View Post

50 Years of Work and Counting – Asrar Qureshi’s Blog Post #1081

Asrar Qureshi reflects on his 50-year career in the pharmaceutical industry, starting in February 1975. He highlights his journey from a medical representative to executive roles and acknowledges influential mentors like Imtiaz Ahmed Taj and Javed Akhtar. Gratitude for personal growth and the blending of work and life is emphasized throughout his narrative.
Share

Impact of Unrest on Pharma Field Work – Asrar Qureshi’s Blog Post #1034

The blog post discusses the significant impacts of ongoing political and social unrest on the pharmaceutical industry, particularly affecting field sales teams and supply chains. Restricted mobility limits engagement with healthcare professionals, creating communication breakdowns and increasing operational costs. The author suggests strategies like enhanced digital engagement and localized operations to mitigate these challenges.
Share